Not applicableStudy completedNCT02240784What this trial is testingEXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)Who this might be right forAcute Hepatic Porphyria Alnylam Pharmaceuticals 136
Not applicableApproved For MarketingNCT04056481What this trial is testingExpanded Access Protocol of Givosiran for Patients With Acute Hepatic PorphyriaWho this might be right forAcute Hepatic Porphyria Alnylam Pharmaceuticals
Not applicableLooking for participantsNCT01561157What this trial is testingLongitudinal Study of the PorphyriasWho this might be right forAcute PorphyriasCutaneous Porphyrias Icahn School of Medicine at Mount Sinai 1,500
Large-scale testing (Phase 3)Study completedNCT03338816What this trial is testingENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)Who this might be right forAcute Hepatic PorphyriaAcute Intermittent PorphyriaPorphyria, Acute Intermittent+4 more Alnylam Pharmaceuticals 94
Testing effectiveness (Phase 2)Study completedNCT05854784What this trial is testingStudy to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Variegate Porphyria (VP)Who this might be right forVariegate Porphyria Clinuvel Pharmaceuticals Limited 6
Not applicableStudy completedNCT01568554What this trial is testingClinical Diagnosis of Acute PorphyriaWho this might be right forHereditary Coproporphyria (HCP)Acute Intermittent Porphyria (AIP)Variegate Porphyria (VP) University of California, San Francisco 148
Not applicableEnded earlyNCT03547297What this trial is testingINSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHPWho this might be right forAcute Hepatic PorphyriaHepatic PorphyriasAcute Intermittent Porphyria (AIP)+4 more Alnylam Pharmaceuticals 212